You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 202171 - 202180 of 207728 results
  1. Rapid breath detection of colorectal cancer with a colorimetric sensor array

    SBC: ISENSE, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): Project Summary/Abstract Recently it has been reported that canines can detect the presence of colon cancer from the scent of exhaled breath, with 91% selectivity and 99% specificity (Sonoda, H. et al., Gut, 2011, 60,814). The prospect of a device which can perform similarly opens the prospect of a rapid, non-invasive, accurate and inexpensive breath test for ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  2. Cell Based Therapy for Treatment of Traumatic Brain Injury

    SBC: ATHERSYS, INC.            Topic: NINDS

    DESCRIPTION (provided by applicant): Previously performed and published studies have demonstrated that MultiStem(R), Athersys' patented adult adherent stem cell product, modulates the inflammatory component of secondary brain injury in rodent models of traumatic brain injury (TBI). Further, there are supporting published data illustrating the efficacy of MultiStem in other CNS injury models ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  3. SBIR PHASE II- 1,136,508YR 1: BASE: 548,090, PARTIALLY FUNDED AT 430,000 (BALANCE TO BE FUNDED: 118,090)YR 2: OPTION: 588,418

    SBC: ECHELON BIOSCIENCES, INC.            Topic: NIAAA

    There needs to better biomarkers of alcohol consumption and alcohol induced organ damage. PEth is a nonoxidative, long-lasting metabolite of ethanol consumption and alcohol related organ damage. PEth may also play a role in cell and organ damage. In this contract antibodies are made to PEth for ELISA research. A cell-based clinical assay for rapid quantification of PEth from blood samples will be ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  4. OTHER FUNCTIONS- EFFICACY OF ORAL AMINOGLYCOSIDE-COCHLEATE FORMULATIONS

    SBC: COORDINATED PROGRAM DEVELOPMENT, LLC            Topic: NIAID

    Aminoglycosides are an important class of antibiotics for the treatment of aerobic, gram-negative bacteria (Pseudomonas, Acinetobacter, Enterobacter) and mycobacteria (Mycobacterium tuberculosis, M. avium), causes of serious co-infections in HIV-infected persons. Widespread use of aminoglycosides has been limited due to their toxicity (nephrotoxicity and ototoxicity) and inconvenient route of admi ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  5. TAS::75 0849::TAS SBIR TOPIC 261 PHASE II, VIODINE: A MOBILE HEALTHY DINING LOCATOR

    SBC: Viocare, Inc.            Topic: NCI

    Development of a fully functioning mobile location-based healthy dining locator tool called VioDine. The VioDine innovation include: 1) use of global positioning system (GPS) based mobile application to locate restaurants within proximity of the VioDine user, 2) nutrition information about the menus available in those restaurants, 3) information about the user's nutrition needs, preferences a ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  6. OTHER FUNCTIONS TARGET SPECIFIC AND DRUG LOADED IRON OXIDE NANOPARTICLES FOR CANCER IMAGING AND THERAPY.

    SBC: Ocean Nanotech LLC            Topic: NCI

    Breast cancer is the most common type of cancer and the second leading cause of cancer death among women with more than one million new cases and 370,000 deaths worldwide yearly. Chemotherapy drugs, such as Doxorubicin, have been used in both pre- and post-operative adjuvant therapy or as the main therapeutic option for breast cancer patients with metastatic disease. Although recent advances in th ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  7. IGF::OT::IGF OTHER FUNCTIONS TOPIC 267, MULTIFUNCTIONAL THERAPEUTICS USING ENGINEERED PLANT VIRUS NANOPARTICLES

    SBC: NanoVector, Inc.            Topic: NCI

    A biologic nanoparticle is the basis of this proposal. The plant virus nanoparticle (PVN) is based on a virus that: exists in the human food chain; is nontoxic and of low immunogenicity; can load medical imaging agents and/or therapeutic drugs into itscargo chamber by a simple process; and can be engineered to identify and enter cancer cells and release drug payloads inside cell structures, suc ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  8. IGF::OT::IGF OTHER FUNCTIONS TOPIC 277, DEVELOPING BH3 PROFILING AS A COMPANION DIAGNOSTIC FOR VELCADE TREATMENT FOR MULTIPLE MYELOMA

    SBC: Eutropics Pharmaceuticals, Inc.            Topic: NCI

    There is a clear need to better define patient-specific treatment strategies for the use of both standard and novel therapies for treating Multiple Myeloma (MM) both to improve efficacy and reduce unnecessary side effects. Eutropics Pharmaceuticals is uniquely positioned to improve therapy efficacy for MM by using a proprietary assay that provides a novel predictive biomarker, BH3 profiling. The a ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. IGF::OT::IGF OTHER FUNCTIONS: TOPIC 287, PHASE II NANOTECHNOLOGY SENSING PLATFORMS

    SBC: OMEGA OPTICS, INC.            Topic: NCI

    Label-free, highly sensitive early cancer detection sensors with required specificity are in great demand. In Phase 1, we experimentally confirmed feasibility of our proposed photonic crystal (PC) microarray with real data better than all reported sensing methods. These include absolute biomolecule mass sensitivity 8.8attograms (10A-18grams), surface mass sensitivity 0.8picogram (10A-12grams)/m ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  10. OTHER FUNCTIONS SBIR PHASE II TOPIC 275, GENERIC ERBITUX FOR TREATMENT OF EGFR+ CANCER

    SBC: CANCER THERAPEUTICS LABORATORIES, INC.            Topic: NCI

    As a continuation of our Phase I SBIR contract with the NCI, this Phase II application is directed towards the further development of a biosimilar Erbitux antibody, designated ch225, for the immunotherapy of EGFR+, KRAS mutation negative colorectal and head and neck cancers. In 2011, there were 141,210 new cases of colon and rectal cancers and 49,380 deaths in the United States accounting for the ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government